The FDA is researching whether or not the drug Topamax’s benefits outweigh the risks of side effects connected to the drug. An FDA Advisory Panel met on September 23, 2011 to review the results of a Risk Evaluation and Mitigation Strategy (REMS). The REMS was approved in March of 2011 and the purpose was to [...]
0 comments
12 Year European Study Links Birth Defects To Topamax
An extended study by the Journal of the American Medical Association (JAMA) seems to find a correlation between drugs like Topamax and severe birth injuries. JAMA conducted a study on 837,795 live-born infants in Denmark from January 1, 1996 through September 30, 2008. Of the 1,532 infants exposed to several different drugs, including topiramate (the [...]
When Does A Child Develop A Birth Injury From Topamax?
Topamax has become well known for increasing the risk of birth defects and limiting the effectiveness of birth control. But, at what point does a child actually develop a cleft palate or cleft lip? While the Topamax drug label gives some indication of what might happen to a child, it leaves little guidance on when [...]
Topamax Lessens Birth Control Effectiveness?
Topamax has been at the center of a firestorm of controversy. From cleft palates to serious side effects, the latest FDA report that Topamax may lessen the effectiveness of birth control. On May 6, 2011 after the FDA moved Topamax from a Class C drug to a Class D drug, many in the medical community [...]
Latest FDA Topamax Birth Defect Update
The FDA has just released a third update on Topamax’s increased risk of cleft lip or cleft palate. Reuters reports that new data shows expecting mothers taking Topamax or Topiramate have an increased risk of oral birth defects. The FDA has stated that mothers taking Topamax are about 20 times more likely to have their [...]
